Julie C Gaardbo1, Hans J Hartling, Andreas Ronit, Karoline Springborg, Lise M R Gjerdrum, Elisabeth Ralfkiær, Kristina Thorsteinsson, Henrik Ullum, Åse B Andersen, Susanne D Nielsen. 1. *Viro-immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; Departments of †Clinical Immunology; ‡Otorhinolaryngology; §Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark; ‖Department of Infectious Diseases, Hvidovre Hospital, University Hospital of Copenhagen, Copenhagen, Denmark; and ¶Department of Infectious Diseases, Odense Hospital, University of Southern Denmark, Odense, Denmark.
Abstract
BACKGROUND: HIV-infected immunological nonresponders fail to immune reconstitute despite optimal treatment. We hypothesized that regulatory T cells (Tregs) are involved in immunological reconstitution. Tregs and Treg subpopulations were measured in blood and Foxp3 cells in lymphoid tissue, and the impact of Tregs on immunological reconstitution was determined. METHODS: HIV-infected individuals on combination antiretroviral therapy for a minimum of 2 years were included. The study population included 14 immunological nonresponders (INR; CD4 T-cell count <200 cells/μL), 33 intermediate responders (CD4 T-cell count 200-500 cells/μL), 30 responders (CD4 T-cell count >500 cells/μL), and 34 healthy controls. Tregs, Treg subpopulations, and intracellular staining for interleukin 10 in peripheral blood were measured using flow cytometry. Foxp3 cells in lymphoid tissue were evaluated using immunolabeling. The CD4 T-cell count was determined at inclusion and after 1 year of follow-up. RESULTS: INR displayed high percentage of Tregs and activated Tregs in peripheral blood accompanied by a high percentage of Tregs expressing interleukin 10, whereas numbers of Foxp3 cells in lymphoid tissue were low. In contrast, responders resembled healthy controls. Finally, in INR, high level of Tregs in blood and Foxp3 cells in lymphoid tissue were associated with higher level of immunological reconstitution after 1 year of follow-up. CONCLUSIONS: In conclusion, altered distribution of Tregs was found in INR. Interestingly, high level of Tregs predicted higher level of immunological reconstitution suggesting a role for Tregs in immunological reconstitution.
BACKGROUND:HIV-infected immunological nonresponders fail to immune reconstitute despite optimal treatment. We hypothesized that regulatory T cells (Tregs) are involved in immunological reconstitution. Tregs and Treg subpopulations were measured in blood and Foxp3 cells in lymphoid tissue, and the impact of Tregs on immunological reconstitution was determined. METHODS:HIV-infected individuals on combination antiretroviral therapy for a minimum of 2 years were included. The study population included 14 immunological nonresponders (INR; CD4 T-cell count <200 cells/μL), 33 intermediate responders (CD4 T-cell count 200-500 cells/μL), 30 responders (CD4 T-cell count >500 cells/μL), and 34 healthy controls. Tregs, Treg subpopulations, and intracellular staining for interleukin 10 in peripheral blood were measured using flow cytometry. Foxp3 cells in lymphoid tissue were evaluated using immunolabeling. The CD4 T-cell count was determined at inclusion and after 1 year of follow-up. RESULTS: INR displayed high percentage of Tregs and activated Tregs in peripheral blood accompanied by a high percentage of Tregs expressing interleukin 10, whereas numbers of Foxp3 cells in lymphoid tissue were low. In contrast, responders resembled healthy controls. Finally, in INR, high level of Tregs in blood and Foxp3 cells in lymphoid tissue were associated with higher level of immunological reconstitution after 1 year of follow-up. CONCLUSIONS: In conclusion, altered distribution of Tregs was found in INR. Interestingly, high level of Tregs predicted higher level of immunological reconstitution suggesting a role for Tregs in immunological reconstitution.
Authors: Souheil-Antoine Younes; Aarthi Talla; Susan Pereira Ribeiro; Evgeniya V Saidakova; Larisa B Korolevskaya; Konstantin V Shmagel; Carey L Shive; Michael L Freeman; Soumya Panigrahi; Sophia Zweig; Robert Balderas; Leonid Margolis; Daniel C Douek; Donald D Anthony; Pushpa Pandiyan; Mark Cameron; Scott F Sieg; Leonard H Calabrese; Benigno Rodriguez; Michael M Lederman Journal: J Clin Invest Date: 2018-10-15 Impact factor: 19.456
Authors: Birgitte Stiksrud; Hans C D Aass; Kristina B Lorvik; Thor Ueland; Marius Trøseid; Anne M Dyrhol-Riise Journal: AIDS Date: 2019-06-01 Impact factor: 4.177
Authors: Mirte Scherpenisse; Neeltje A Kootstra; Margreet Bakker; Ben Berkhout; Alexander O Pasternak Journal: mBio Date: 2021-03-09 Impact factor: 7.867
Authors: Jacqueline María Valverde-Villegas; Maria Cristina Cotta Matte; Rúbia Marília de Medeiros; José Artur Bogo Chies Journal: J Immunol Res Date: 2015-10-19 Impact factor: 4.818